| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/22/1998 | CN1188471A 1,4-disubstituted piepridine derivatives |
| 07/22/1998 | CN1188413A Pharmaceutical and diet formulations for prophylaxis and treatment of gastrointestinal disorders |
| 07/22/1998 | CN1188412A Means for treating radiation injuries |
| 07/22/1998 | CN1188411A Compressed dry-granulation desogestrel tablets |
| 07/22/1998 | CN1188410A Use of N-cyclohexyl benzamides for treating bowel disorders |
| 07/22/1998 | CN1188409A 抗真菌剂 Antifungal agents |
| 07/22/1998 | CN1188407A New pharmaceutical composition with anaesthetic effect |
| 07/22/1998 | CN1188112A Vinyl pyrrolidine cephalosporins with basic substituents |
| 07/22/1998 | CN1188111A 4-hydroxy-piperidine derivatives |
| 07/22/1998 | CN1187991A Calcium tablet |
| 07/22/1998 | CN1187948A Health-care chitosan-chitin food |
| 07/22/1998 | CN1039194C Improved pulsatile once-a-day-delivery systems for minocycline |
| 07/22/1998 | CA2227112A1 Five-membered heterocycles having biphenylsulfonyl substitution, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 07/21/1998 | US5783708 Hexahydroisoindole derivatives |
| 07/21/1998 | US5783682 Oligonucleotide mimics having nitrogen-containing linkages |
| 07/21/1998 | US5783661 Polypeptide encoded by a nucleic acid capable of hybridizing under stringent conditions to a cyclin e nucleotide sequence |
| 07/21/1998 | US5783606 Deprenyl compounds for treatment of glaucoma |
| 07/21/1998 | US5783605 Administering methyl or ethyl phenylacetamide as helper inducer |
| 07/21/1998 | US5783602 Leukotriene-B4 derivatives, process for their production and their use as pharmaceutical agents |
| 07/21/1998 | US5783601 External skin-care composition |
| 07/21/1998 | US5783600 Carboxyalkylethers, formulations, and treatment of vascular diseases |
| 07/21/1998 | US5783599 Methods of treating cancer and viral infections with 5-iodo-6-amino-and 5-iodo-6-nitroso-1 2-benzopyrones |
| 07/21/1998 | US5783598 Antiretroviral naphthoquinone compounds compositions and uses thereof |
| 07/21/1998 | US5783596 Dithiocarbamates block the induced expression of the endothelial cell surface adhesion molecule vcam-1 |
| 07/21/1998 | US5783594 Administering to treat glioma, colon cancer and immunological disordaers |
| 07/21/1998 | US5783592 Formulations for lipophilic compounds |
| 07/21/1998 | US5783591 Administration of oxazolidinone and pyrolidinone compounds for the treatment of inflammation |
| 07/21/1998 | US5783590 6-heterocyclic-4-amino-1,2,2A,3,4,5-hexahydrobenz CD!indoles |
| 07/21/1998 | US5783589 2-saccharinylmethyl aryl and arloxy acetates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| 07/21/1998 | US5783587 Psychological and brain disorders |
| 07/21/1998 | US5783585 Solid bulk compositions containing quinolone carboxylic acids or naphthyridine carboxylic acids in free base form |
| 07/21/1998 | US5783583 Nalmefene, withdrawal from drug dependence, side effect reduction |
| 07/21/1998 | US5783579 Spiro-substituted azacyclic-substituted piperazino derivatives as neurokinin antagonists |
| 07/21/1998 | US5783576 Benzoyl guanidine derivatives, the preparation thereof and their use in pharmaceutical compositions |
| 07/21/1998 | US5783574 Imidazolylakyl derivatives of imidazo 5,1-c! 1,4!benzoxazin-1-one process for their preparation |
| 07/21/1998 | US5783573 Pharmaceuticals which promote gastrointestinal blood circulation |
| 07/21/1998 | US5783572 Treatment of neurodegenerative disorders |
| 07/21/1998 | US5783569 An immunostimulant which does not cause fever or inflammation, derived from yeast, wound healing |
| 07/21/1998 | US5783568 Methods for treating cancer and other cell proliferative diseases |
| 07/21/1998 | US5783561 Anti-gram-positive bacterial methods and materials |
| 07/21/1998 | US5783454 Method for the preparation of free radical pharmaceuticals using selenium conjugates |
| 07/21/1998 | US5783408 Culturing cellular material in presence of compound, determining whether compound stimulates micromotion of cells in vitro |
| 07/21/1998 | US5783403 Cancer diagnosis, therapy |
| 07/21/1998 | US5783306 Hyperpolarizable compounds and devices fabricated therefrom |
| 07/21/1998 | US5783215 Pharmaceutical preparation |
| 07/21/1998 | US5783208 Transdermal drug delivery matrix for coadministering estradiol and another steroid |
| 07/21/1998 | US5783207 Holder for soluble matrix containing controlled amounts of nicotine as a cigarette replacement for treatment of nicotine withdrawal |
| 07/21/1998 | US5783201 Administering a tin compound |
| 07/21/1998 | US5783199 Anaesthetic mixtures containing enflurane or isoflurane in combination with sevoflurane or desflurane |
| 07/21/1998 | US5783177 Forming films on mammalian skin, wound dressings, wound closure |
| 07/21/1998 | US5783172 Dentifrice compositions comprising an abrasive system and a surfactant system |
| 07/21/1998 | US5783150 Test kit for determining the level of ascorbic acid in a patient's body |
| 07/21/1998 | CA2224910A1 Cardiac diseases improving agents |
| 07/21/1998 | CA2067133C Liposome microreservoir composition and method |
| 07/21/1998 | CA1339965C Antiparasitic agents |
| 07/21/1998 | CA1339964C Substituted adenine derivatives useful as therapeutic agents |
| 07/17/1998 | CA2448630A1 Pharmaceutical composition of fenofibrate presenting a high biodisponibility and its preparation process |
| 07/17/1998 | CA2448623A1 Pharmaceutical composition of fenofibrate presenting a high biodisponibility and its preparation process |
| 07/17/1998 | CA2372561A1 Pharmaceutical composition of fenofibrate presenting a high biodisponibility and its preparation process |
| 07/17/1998 | CA2227132A1 Pharmaceutical compounds |
| 07/16/1998 | WO1998030900A2 Screening method for compounds active in treating myopia and hypermetropia |
| 07/16/1998 | WO1998030709A2 Non-immunogenic prodrugs and selectable markers for use in gene therapy |
| 07/16/1998 | WO1998030685A2 Purification and/or concentration of dna by cross-flow filtration, separation of endotoxins from a nucleic acid preparation |
| 07/16/1998 | WO1998030595A1 Oligosulfated hyaluronic acid |
| 07/16/1998 | WO1998030574A1 Tricyclic erythromycin derivatives |
| 07/16/1998 | WO1998030566A1 Cyclic sulfone derivatives |
| 07/16/1998 | WO1998030561A1 2-(1,2,4-triazole-1-yl)-1,3,4-thiadiazole derivatives having an effect on the c.n.s. and the heart |
| 07/16/1998 | WO1998030560A1 Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of begnin prostatic hyperplasia |
| 07/16/1998 | WO1998030559A1 Process for the production of tetrazolylbenzopyrans |
| 07/16/1998 | WO1998030558A2 Tricyclic compounds useful for inhibition of farnesyl protein transferase |
| 07/16/1998 | WO1998030556A1 Novel benzofuranone derivatives and process for producing the same |
| 07/16/1998 | WO1998030555A1 Treatment for cancer and compounds for use therewith |
| 07/16/1998 | WO1998030553A1 Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof |
| 07/16/1998 | WO1998030551A1 MACROCYCLIC INHIBITORS OF MATRIX METALLOPROTEINASES AND TNFα SECRETION |
| 07/16/1998 | WO1998030550A1 2,4-diaminopyrimidine compounds as anti-cancer agents |
| 07/16/1998 | WO1998030548A1 5-HT2c RECEPTOR AGONISTS AND AMINOALKYLINDAZOLE DERIVATIVES |
| 07/16/1998 | WO1998030542A1 Vitronectin receptor antagonists |
| 07/16/1998 | WO1998030541A1 C-terminal ketone hydroxamic acid inhibitors of matrix metalloproteinases and tnfa secretion |
| 07/16/1998 | WO1998030537A1 Nitric oxide synthase inhibitors |
| 07/16/1998 | WO1998030530A1 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| 07/16/1998 | WO1998030247A1 A method and composition for cancer treatment by enzymatic conversion of soluble radioactive toxic agents |
| 07/16/1998 | WO1998030242A2 Photochemotherapeutic compositions |
| 07/16/1998 | WO1998030239A2 Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this procedure |
| 07/16/1998 | WO1998030228A1 Compounds and their combinations for the treatment of influenza infection |
| 07/16/1998 | WO1998030224A1 Inhibitor of immunoglobulin e antibody production |
| 07/16/1998 | WO1998030223A1 Cytokine related treatments of disease |
| 07/16/1998 | WO1998030222A1 Use of diadenosine polyphosphates for reducing blood pressure |
| 07/16/1998 | WO1998030220A1 Attenuation of opioid tolerance by inhibiting inducible nitric oxide synthase pathways in the treatment of pain |
| 07/16/1998 | WO1998030219A1 Method for treatment of cns-involved lysosomal storage diseases |
| 07/16/1998 | WO1998030218A1 Substituted bis-acridines and related compounds as ccr5 receptor ligands, anti-inflammatory agents and anti-viral agents |
| 07/16/1998 | WO1998030217A1 Supplement for dialysis patients |
| 07/16/1998 | WO1998030216A1 Use of angiotensin ii antagonists to treat symptomatic heart failure |
| 07/16/1998 | WO1998030215A1 Liposome-based topical tretinoin formulation |
| 07/16/1998 | WO1998030214A1 Use of dichlorobenzyl alcohol for preparing a preparation for topical treatment of inflammation and a preparation containing dichlorobenzyl alcohol |
| 07/16/1998 | WO1998030213A2 Use of the ah receptor and ah receptor ligands to treat or prevent the cytopathicity of viral infection |
| 07/16/1998 | WO1998030212A2 Use of aminothiazoles for treating wounds and skin |
| 07/16/1998 | WO1998030210A1 Patch containing isosorbide dinitrate |
| 07/16/1998 | WO1998030208A1 Tablet for the controlled release of active agents |
| 07/16/1998 | WO1998030205A1 Emulsion vehicle for poorly soluble drugs |
| 07/16/1998 | WO1998030203A2 Transdermal therapeutic system |